Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Iris Erdmann"'
Autor:
Alexandra Chabot, Gabriela Senti, Iris Erdmann, Bettina M. Prinz, Brunello Wüthrich, Lara Šošić, Thomas M. Kündig, Pål Johansen
Publikováno v:
Frontiers in Allergy, Vol 3 (2022)
BackgroundSubcutaneous venom immunotherapy (VIT) represents an effective treatment against bee venom allergy. However, it involves long treatment times, high costs, and the risk of adverse events (AEs). Shorter, safer, and cheaper treatment options a
Externí odkaz:
https://doaj.org/article/60f0105985564c1a941a0abd78ba3b93
Autor:
Iris Erdmann, E. Paul Scheidegger, Lucie Heinzerling, Thomas M. Kündig, John B. Lowe, Bernhard Odermatt, Frauke K. Koch, Günter Burg
Publikováno v:
The Journal of Immunology. 168:2139-2146
The first step of leukocyte extravasation, leukocyte rolling, is mediated by E-, P-, and L-selectins. Mice deficient for α-1,3-fucosyltransferase VII (FucTVII)−/− are characterized by deficiency of E-, P-, and L-selectin ligand activity. This mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ec36b20b9b7546a3687332fc9719d87
https://doi.org/10.4049/jimmunol.168.5.2139
https://doi.org/10.4049/jimmunol.168.5.2139
Autor:
Gabriela Senti, Thomas M. Kündig, Julia M. Martinez-Gomez, Reto Crameri, Pål Johansen, Iris Erdmann
Background: IgE-mediated allergy can be treated by subcutaneous allergen-specific immunotherapy (SIT). However, the percentage of allergic patients undergoing SIT is low, mainly due to the long duration of the therapy and the risk of severe systemic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa65f48d778030b2354df05ea03db5c8
https://www.zora.uzh.ch/id/eprint/29777/
https://www.zora.uzh.ch/id/eprint/29777/
Autor:
Mella I. Diaz, Nicole Graf, Iris Erdmann, Bettina M. Prinz Vavricka, John J. Simard, Thomas M. Kündig, Richard Markus, Pål Johansen, Stephen J. Mccormack, Brunello Wüthrich, Reto Crameri, Gabriela Senti
The only causative treatment for IgE-mediated allergies is allergen-specific immunotherapy. However, fewer than 5% of allergy patients receive immunotherapy because of its long duration and risk of allergic side effects. We aimed at enhancing s.c. im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49ad5e6bb74a63048708cb94d589166d
https://europepmc.org/articles/PMC2582048/
https://europepmc.org/articles/PMC2582048/
Autor:
John J. L. Simard, K. Zepter, Thomas M. Kündig, F. Koch, Kevin J. Maloy, Pål Johansen, Tazio Storni, Iris Erdmann, Gabriela Senti, A. C. Häffner, Adrian Bot, Brunello Wüthrich
Publikováno v:
European journal of immunology. 35(2)
Research to enhance the efficiency of vaccines focuses mainly on improving either the adjuvant or the type and form of the antigen. This study evaluates the influence of the administration route on the efficiency of a peptide-based vaccine. Peptide v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8427598d9f75494b766345faace6d841
https://pubmed.ncbi.nlm.nih.gov/15682446
https://pubmed.ncbi.nlm.nih.gov/15682446
Autor:
Thomas M. Kündig, Wolfgang A. Renner, Gary T. Jennings, Franziska Lechner, Thomas Bächi, Peter Sebbel, Paul Pumpens, Andrea Jegerlehner, Iris Erdmann, Martin F. Bachmann, Alain Tissot, Tazio Storni
Publikováno v:
Vaccine. 20(25-26)
Virus like particles (VLPs) are known to induce potent B cell responses in the absence of adjuvants. Moreover, epitope-specific antibody responses may be induced by VLPs that contain peptides inserted in their immunodominant regions. However, due to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::737ddf85f6874f0346aa9b4eec11da78
https://pubmed.ncbi.nlm.nih.gov/12163261
https://pubmed.ncbi.nlm.nih.gov/12163261